Humana Faces Sharp Decline In Medicare Star Ratings For 2025, Braces For 2026 Revenue Hit

According to preliminary data from the Centers for Medicare and Medicaid Services (CMS), Humana Inc. (NYSE:HUM) faces a substantial drop in its Medicare Advantage (MA) Star Ratings for 2025.

The data available in the CMS Plan Finder as of October 1, 2024, reveals that only 25% of Humana’s members are enrolled in plans rated four stars and above, a sharp decline from 94% in 2024.

The decrease is primarily driven by contract H5216, which holds around 45% of Humana’s MA membership and 90% of its employer group waiver plan (Group MA) membership.

Also Read: FTC Investigation Uncovers Anti-Competitive Practices By Handful Of Pharmacy Benefit Managers, Including CVS Health, UnitedHealth.

H5216’s rating dropped to 3.5 stars ...